优于安慰剂：特普利尤单抗可保护 1 型糖尿病患者的 β 细胞功能

{"title":"优于安慰剂：特普利尤单抗可保护 1 型糖尿病患者的 β 细胞功能","authors":"Miriam Sonnet","doi":"10.1007/s15014-024-5398-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508648,"journal":{"name":"Pädiatrie","volume":"273 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Besser als Placebo: Teplizumab erhält β-Zell-Funktion bei Typ-1-Diabetes\",\"authors\":\"Miriam Sonnet\",\"doi\":\"10.1007/s15014-024-5398-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508648,\"journal\":{\"name\":\"Pädiatrie\",\"volume\":\"273 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pädiatrie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s15014-024-5398-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pädiatrie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s15014-024-5398-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}